Heplatinum Pharmaceuticals-B (02142) opened higher in early tradingdrakecasinonodepositbonus, once rose by 15%drakecasinonodepositbonus, shares retreated slightly to a gain of 6drakecasinonodepositbonus.43%, currently reported 1drakecasinonodepositbonus.49 Hong Kong dollars, with a turnover of 8.0032 million Hong Kong dollars.

Heplatinum Pharmaceuticals announced that Nona Biotech (Suzhou) Co., Ltd., a wholly-owned subsidiary of the company, has entered into a license and option agreement with AstraZeneca (AZN.US) for preclinical monoclonal antibodies used to create tumor-targeted therapies.